Diagnostic Value of Novel Presepsin and Inflammatory Biomarkers in Predicting the Clinical Course of COVID-19
Aim:The diagnostic value of inflammatory markers to determine the severity of Coronavirus disease-2019 (COVID-19) is postulated in some recent studies, but conclusions were inconsistent. Hence, we intend to examine the utility of presepsin, procalcitonin and C-reactive protein in predicting the seve...
Saved in:
| Published in: | Haseki tıp bülteni Vol. 59; no. 5; pp. 358 - 362 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Galenos Yayinevi
01-11-2021
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim:The diagnostic value of inflammatory markers to determine the severity of Coronavirus disease-2019 (COVID-19) is postulated in some recent studies, but conclusions were inconsistent. Hence, we intend to examine the utility of presepsin, procalcitonin and C-reactive protein in predicting the severity of COVID-19 infection.Methods:Single-center cross-sectional study was undertaken at the Intensive care unit of a university hospital. Eighty consecutive cases diagnosed with Severe Acute Respiratory syndrome-Coronavirus-2 RNA between October 2020 and July 2021 were classified according to the severity of the disease. Laboratory data related to Procalcitonin and C-reactive protein was retrieved from investigations coinciding with the day of admission. The stored plasma was subjected to an enzyme-linked immunosorbent assay to determine plasma presepsin levels. Statistical test for measures of screening was employed and a receiver operator curve was generated.Results:We have determined that presepsin is the most sensitive prognostic indicator (93.3%) with a strong statistical association (p<0.001) for COVID-19. 15.99 ng/L could be used as a reference level to predict the progressive clinical course. Relatively lower sensitivity (88%) and positive statistical correlation (p=0.049) of C-reactive protein with high-risk infection were also observed. Procalcitonin showed limited diagnostic and prognostic value in our series.Conclusion:Our findings seem to demonstrate the role of presepsin in providing prognostic information in COVID-19 patients. Therefore, we suggest that early monitoring of presepsin with routine marker profile might help in identifying patients suffering from a more severe disease. |
|---|---|
| ISSN: | 1302-0072 2147-2688 |
| DOI: | 10.4274/haseki.galenos.2021.7653 |